During SupplySide West, in early October, news broke about the finding of DMAA analogues in 12 of 14 dietary supplements tested by a group led by Pieter Cohen, MD, Cambridge Health Alliance, Harvard Medical School. The researchers found 1,3-dimethylbutylamine (DMBA) in sports, weight and brain health supplements and urged in their publication (Drug Testing & Analysis) that regulatory agencies should quickly remove this compound from dietary supplements.  

INSIDER Senior Editor Steve Myers caught up with longtime sports nutrition expert Anthony Almada, CEO and Founder of Vitargo Global Sciences, to discuss the situation with DMBA and how these types of quality and safety issues affect marketing and product development in the sports nutrition segment.